Broad Spectrum of Formulations
Boehringer Ingelheim offers sophisticated pre-formulation, formulation and pharmaceutical process development. The dosage form portfolio ranges from solutions, highly concentrated liquid formulations, suspensions, lyophilized or spray-dried powders to inhalable presentations combined with state-of-the art proprietary application systems.
Efficient development of formulation and fill & finish processes
As an integrated part of our cost-efficient fast track development approach we offer the delivery of formulations and dosage forms suitable for toxicological studies and for clinical phase I studies within15 months after start of development. Long-lasting know-how with protein containing pharmaceuticals and the availability of high end analytical science is a prerequisite to efficiently develop the appropriate robust formulation and fill & finish process.
Boehringer Ingelheim's technological capabilities are broad and well established. We successfully, developed liquid and freeze dried products for the market as well as powders and suspensions for inhalation including the provision of inhaler devices and the characterization of aerosol.
Best quality
The major goal of our pharmaceutical development is to design and generate a cost-effective, robust, high yield process which guarantees the highest stability and reproducibility of drug product quality.